{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:22:51Z","timestamp":1789474971618,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100024109","name":"University of Gda\u0144sk","doi-asserted-by":"crossref","award":["BMN no. 539-T080-B063-23"],"award-info":[{"award-number":["BMN no. 539-T080-B063-23"]}],"id":[{"id":"10.13039\/501100024109","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100024109","name":"University of Gda\u0144sk","doi-asserted-by":"crossref","award":["DS no. 530-8228-D738-23"],"award-info":[{"award-number":["DS no. 530-8228-D738-23"]}],"id":[{"id":"10.13039\/501100024109","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["Innovation Incubator 4.0"],"award-info":[{"award-number":["Innovation Incubator 4.0"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The synthesis, spectral properties, thermal analysis, structural characterization and in silico prediction of pharmacokinetic parameters of tetramethylammonium (compound <jats:bold>1<\/jats:bold>) and tetraethylammonium (compound <jats:bold>2<\/jats:bold>) salt of nimesulide were described in this article. Both compounds crystallize in the monoclinic <jats:italic>P<\/jats:italic>2<jats:sub>1<\/jats:sub>\/n space group, with one tetraalkylammonium cation and one nimesulide anion in the asymmetric unit and their crystal structures are stabilized by C\u2013H\u00b7\u00b7\u00b7O hydrogen bonds between ions. Additionally, structures of title compounds are stabilized by \u03c0\u2013\u03c0 interactions (compound <jats:bold>1<\/jats:bold>), or C\u2013H\u00b7\u00b7\u00b7\u03c0 interactions (compound <jats:bold>2<\/jats:bold>) between nimesulide anions. The TG and DSC measurements show that compound <jats:bold>1<\/jats:bold> melts at a temperature higher than nimesulide, whereas the compound <jats:bold>2<\/jats:bold> melts at a temperature lower than nimesulide. The MALDI-TOF, <jats:sup>1<\/jats:sup>H NMR, <jats:sup>13<\/jats:sup>C NMR and ATR-FTIR analyses confirm the SCXRD study, that in compounds <jats:bold>1<\/jats:bold> and <jats:bold>2<\/jats:bold> nimesulide exists in an ionized form. Studies performed by SWISS ADME and ProTOX II tools, predict to be oral bioavailability of both salts obtained, and one of them (compound <jats:bold>1<\/jats:bold>) is predicted to be well-absorbed by digestive system, while both compounds obtained are classified into toxicity class 4.<\/jats:p>","DOI":"10.1038\/s41598-023-44557-x","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T09:02:22Z","timestamp":1697101342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The synthesis, thermal behaviour, spectral and structural characterization, and in silico prediction of pharmacokinetic parameters of tetraalkylammonium salts of non-steroidal anti-inflammatory drug nimesulide"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9870-4123","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Rybczy\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4559-7870","authenticated-orcid":false,"given":"Artur","family":"Sikorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"issue":"5","key":"44557_CR1","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1021\/cg3002948","volume":"12","author":"S Aitipamula","year":"2012","unstructured":"Aitipamula, S. et al. Polymorphs, salts, and cocrystals: What\u2019s in a name?. Cryst. Growth Des. 12(5), 2147\u20132152 (2012).","journal-title":"Cryst. Growth Des."},{"issue":"4","key":"44557_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ajps.2015.03.003","volume":"10","author":"AK El-Zhry El-Yafi","year":"2015","unstructured":"El-Zhry El-Yafi, A. K. & El-Zein, H. Technical crystallization for application in pharmaceutical material engineering: Review article. Asian J. Pharm. Sci. 10(4), 283\u2013291 (2015).","journal-title":"Asian J. Pharm. Sci."},{"issue":"2","key":"44557_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cryst8020101","volume":"8","author":"R Thakuria","year":"2018","unstructured":"Thakuria, R. & Sarma, B. Drug-drug and drug-nutraceutical cocrystal\/salt as alternative medicine for combination therapy: A crystal engineering approach. Crystals 8(2), 1\u201339 (2018).","journal-title":"Crystals"},{"issue":"1","key":"44557_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrd1280","volume":"3","author":"S Datta","year":"2004","unstructured":"Datta, S. & Grant, D. J. W. Crystal structures of drugs: Advances in determination, prediction and engineering. Nat. Rev. Drug Discov. 3(1), 42\u201357 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"44557_CR5","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/j.2042-7158.2010.01133.x","volume":"62","author":"T Friscic","year":"2010","unstructured":"Friscic, T. & Jones, W. Benefits of cocrystalisation in pharmaceutical materials science: An update. J. Pharm. 62(11), 1547\u20131559 (2010).","journal-title":"J. Pharm."},{"key":"44557_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.07.037","volume":"419","author":"N Qiao","year":"2011","unstructured":"Qiao, N., Schlindwein, W., Malek, N., Davis, A. & Trappitt, G. Pharmaceutical cocrystals: An overview. Int. J. Pharm. 419, 1\u201311 (2011).","journal-title":"Int. J. Pharm."},{"key":"44557_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/9783527610112","volume-title":"Making Crystal by Design","author":"D Braga","year":"2006","unstructured":"Braga, D. & Grepioni, F. Making Crystal by Design (Wiley-VCH Verlag GmbH & Co, 2006)."},{"key":"44557_CR8","doi-asserted-by":"publisher","first-page":"9952","DOI":"10.1021\/ja403264c","volume":"135","author":"GR Desiraju","year":"2013","unstructured":"Desiraju, G. R. Crystal engineering. From molecules to materials. J. Am. Chem. Soc. 135, 9952\u20139967 (2013).","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"44557_CR9","first-page":"23132","volume":"7","author":"G Chaurasia","year":"2016","unstructured":"Chaurasia, G. A review on pharmaceutical preformulation studies in formulation and development of new drug molecules. Int. J. Pharm. Sci. Res. 7(6), 23132\u201332320 (2016).","journal-title":"Int. J. Pharm. Sci. Res."},{"issue":"1\u20134","key":"44557_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0022-0248(99)00819-2","volume":"211","author":"BY Shekunov","year":"2000","unstructured":"Shekunov, B. Y. & York, P. Crystallization processes in pharmaceutical technology and drug delivery design. J. Cryst. Growth 211(1\u20134), 122\u2013136 (2000).","journal-title":"J. Cryst. Growth"},{"key":"44557_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejps.2013.10.015","volume":"57","author":"CA Bergstr\u00f6m","year":"2014","unstructured":"Bergstr\u00f6m, C. A. et al. Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs. Eur. J. Pharm. Sci. 57, 173\u2013199 (2014).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"44557_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.addr.2003.10.008","volume":"56","author":"D Singhal","year":"2004","unstructured":"Singhal, D. & Curatolo, W. Drug polymorphism and dosage form design: A practical perspective. Adv. Drug Deliv. Rev. 56(3), 335\u2013347 (2004).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"44557_CR13","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/S0928-0987(00)00181-0","volume":"2000","author":"JB Dressman","year":"2000","unstructured":"Dressman, J. B. & Reppas, C. In vitro\u2013in vivo correlations for lipophilic, poorly water-soluble drugs. Eur. J. Pharm. Sci. 2000(11), S73\u2013S80 (2000).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"44557_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nmat2200","volume":"7","author":"A Van de Walle","year":"2008","unstructured":"Van de Walle, A. A complete representation of structure\u2013property relationships in crystals. Nat. Mat. 7(6), 455\u2013458 (2008).","journal-title":"Nat. Mat."},{"issue":"8B","key":"44557_CR15","doi-asserted-by":"publisher","first-page":"B66","DOI":"10.1088\/0022-3727\/26\/8B\/010","volume":"26","author":"J Bernstein","year":"1993","unstructured":"Bernstein, J. Crystal growth, polymorphism and structure-property relationships in organic crystals. J. Phys. D: Appl. Phys. 26(8B), B66\u2013B76 (1993).","journal-title":"J. Phys. D: Appl. Phys."},{"issue":"14","key":"44557_CR16","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1002\/chem.200900041","volume":"15","author":"VH Gessner","year":"2009","unstructured":"Gessner, V. H., D\u00e4schlein, C. & Strohmann, C. Structure formation principles and reactivity of organolithium compounds. Chem. A Eur. J. 15(14), 3320\u20133334 (2009).","journal-title":"Chem. A Eur. J."},{"issue":"47","key":"44557_CR17","doi-asserted-by":"publisher","first-page":"17048","DOI":"10.1021\/ja907674c","volume":"131","author":"CB Aaker\u00f6y","year":"2009","unstructured":"Aaker\u00f6y, C. B., Forbes, S. & Desper, J. Using cocrystals to systematically modulate aqueous solubility and melting behaviour of an anticancer drug. J. Am. Chem. Soc. 131(47), 17048\u201317049 (2009).","journal-title":"J. Am. Chem. Soc."},{"key":"44557_CR18","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1208\/s12248-008-9061-4","volume":"10","author":"F Kesisoglou","year":"2008","unstructured":"Kesisoglou, F. & Wu, Y. Understanding the effect of API properties on bioavailability through absorption modeling. AAPS J. 10, 516\u2013525 (2008).","journal-title":"AAPS J."},{"key":"44557_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-3-642-61015-8_8","volume":"1996","author":"JP Griffin","year":"1996","unstructured":"Griffin, J. P. & D\u2019Arcy, P. F. Synergistic Drug Interactions. Handb. Exp. Pharmacol. 1996, 235\u2013248 (1996).","journal-title":"Handb. Exp. Pharmacol."},{"key":"44557_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coisb.2017.05.005","volume":"4","author":"ZB Weinstein","year":"2017","unstructured":"Weinstein, Z. B., Bender, A. & Cokol, M. Prediction of synergistic drug combinations. Curr. Opin. Syst. Biol. 4, 24\u201328 (2017).","journal-title":"Curr. Opin. Syst. Biol."},{"issue":"7","key":"44557_CR21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nbt.1549","volume":"27","author":"J Leh\u00e1r","year":"2009","unstructured":"Leh\u00e1r, J. et al. Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat. Biotechnol. 27(7), 659\u2013666 (2009).","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"44557_CR22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.12968\/npre.2017.15.7.356","volume":"15","author":"D Robertson","year":"2017","unstructured":"Robertson, D. Agonistic and antagonistic drug action. Nurse Prescrib. 15(7), 356\u2013358 (2017).","journal-title":"Nurse Prescrib."},{"issue":"2","key":"44557_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1517\/14656566.1.2.277","volume":"1","author":"A Bennett","year":"2000","unstructured":"Bennett, A. & Villa, G. Nimesulide: An NSAID that preferentially inhibits COX-2 and has various unique pharmacological activities. Expert Opin. Pharmacother. 1(2), 277\u2013286 (2000).","journal-title":"Expert Opin. Pharmacother."},{"key":"44557_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0002-9343(97)00203-9","volume":"104","author":"JR Vane","year":"1998","unstructured":"Vane, J. R. & Botting, R. M. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am. J. Med. 104, 2\u20138 (1998).","journal-title":"Am. J. Med."},{"issue":"1","key":"44557_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1185\/03007995.2015.1100986","volume":"32","author":"HG Kress","year":"2016","unstructured":"Kress, H. G. et al. Acute pain: A multifaceted challenge\u2014the role of nimesulide. Curr. Med. Res. 32(1), 23\u201336 (2016).","journal-title":"Curr. Med. Res."},{"issue":"3","key":"44557_CR26","first-page":"507","volume":"51","author":"L Dupont","year":"1995","unstructured":"Dupont, L., Pirotte, B., Masereel, B., Delarge, J. & Geczy, J. Nimesulide. Acta Cryst. 51(3), 507\u2013509 (1995).","journal-title":"Acta Cryst."},{"issue":"7","key":"44557_CR27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0041-0101(89)90037-8","volume":"27","author":"U Anthoni","year":"1989","unstructured":"Anthoni, U. et al. Tetramine: Occurrence in marine organisms and pharmacology. Toxicon 27(7), 707\u2013716 (1989).","journal-title":"Toxicon"},{"key":"44557_CR28","volume-title":"Pharmacology in Medicine","author":"JR DiPalma","year":"1971","unstructured":"DiPalma, J. R., McGraw-Hill, E. & Drill\u2019s, E. D. Pharmacology in Medicine (McGraw-Hill, 1971)."},{"key":"44557_CR29","first-page":"417","volume":"6","author":"JH Burn","year":"1915","unstructured":"Burn, J. H. & Dale, H. H. The action of certain quaternary ammonium bases. J. Pharmacol. Exp. Ther. 6, 417\u2013438 (1915).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"44557_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF00512058","volume":"328","author":"C Neef","year":"1984","unstructured":"Neef, C., Oosting, R. & Meijer, D. K. F. Structure-pharmacokinetics relationship of quaternary ammonium compounds. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 328(2), 103\u2013110 (1984).","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"issue":"1","key":"44557_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1113\/jphysiol.1977.sp011945","volume":"270","author":"AL Kleinhaus","year":"1977","unstructured":"Kleinhaus, A. L. & Prichard, J. W. Close relation between TEA responses and Ca-dependent membrane phenomena of four identified leech neurons. J. Physiol. 270(1), 181\u2013194 (1977).","journal-title":"J. Physiol."},{"key":"44557_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1113\/jphysiol.2003.043885","volume":"551","author":"G Akk","year":"2003","unstructured":"Akk, G. & Steinbach, J. H. Activation and block of mouse muscle-type nicotinic receptors by tetraethylammonium. J. Physiol. 551, 155\u2013168 (2003).","journal-title":"J. Physiol."},{"issue":"2","key":"44557_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1107\/S2052520616003954","volume":"72","author":"CR Groom","year":"2016","unstructured":"Groom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. The Cambridge Structural Database. Acta Crystallogr. B Struct. Sci. Cryst. Eng. Mater. 72(2), 171\u2013179 (2016).","journal-title":"Acta Crystallogr. B Struct. Sci. Cryst. Eng. Mater."},{"issue":"6","key":"44557_CR34","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/jps.22464","volume":"100","author":"P Sanphui","year":"2011","unstructured":"Sanphui, P., Sarma, B. & Nangia, A. Phase transformation in conformational polymorphs of nimesulide. J. Pharm. Sci. 100(6), 2287\u20132299 (2011).","journal-title":"J. Pharm. Sci."},{"issue":"17","key":"44557_CR35","doi-asserted-by":"publisher","first-page":"8681","DOI":"10.1021\/acs.inorgchem.6b01241","volume":"55","author":"CN Banti","year":"2016","unstructured":"Banti, C. N., Papatriantafyllopoulou, C., Manoli, M., Tasiopoulos, A. J. & Hadjikakou, S. K. Nimesulide silver metallodrugs containing the mitochondriotropic triaryl derivatives of pnictogen; anticancer activity against human breast cancer cells. Inorg. Chem. 55(17), 8681\u20138696 (2016).","journal-title":"Inorg. Chem."},{"issue":"1","key":"44557_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1021\/acs.cgd.0c01132","volume":"21","author":"M Wang","year":"2021","unstructured":"Wang, M. et al. Similar but not the same: Difference in the ability to form cocrystals between nimesulide and the pyridine analogues. Cryst. Growth Des. 21(1), 287\u2013296 (2021).","journal-title":"Cryst. Growth Des."},{"key":"44557_CR37","unstructured":"Geczy, J. Nimesulide salt cyclodextrin inclusion complexes. U.S. Patent no. 5744165 (1998)."},{"issue":"5","key":"44557_CR38","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1039\/b211295g","volume":"1","author":"SS Braga","year":"2003","unstructured":"Braga, S. S. et al. Encapsulation of sodium nimesulide and precursors in \u03b2-cyclodextrin. Org. Biomol. Chem. 1(5), 873\u2013878 (2003).","journal-title":"Org. Biomol. Chem."},{"key":"44557_CR39","unstructured":"CrysAlis CCD and CrysAlis RED. Version 1.171.36.24. Oxford Diffraction Ltd. (Yarnton, 2012)."},{"issue":"1","key":"44557_CR40","first-page":"3","volume":"71","author":"GM Sheldrick","year":"2015","unstructured":"Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Cryst. 71(1), 3\u20138 (2015).","journal-title":"Acta Cryst."},{"key":"44557_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1107\/S0021889802022112","volume":"36","author":"AL Spek","year":"2003","unstructured":"Spek, A. L. Single-crystal structure validation with the program PLATON. J. Appl. Cryst. 36, 7\u201313 (2003).","journal-title":"J. Appl. Cryst."},{"key":"44557_CR42","unstructured":"Johnson, C. K. ORTEP II. Report ORNL-5138. ORNL (Oak Ridge, 1976)."},{"key":"44557_CR43","unstructured":"Motherwell S. & Clegg. S. PLUTO-78. Program for Drawing and Molecular Structure. UC (Cambridge, 1978)."},{"issue":"2","key":"44557_CR44","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1107\/S0021889807067908","volume":"41","author":"CF Macrae","year":"2008","unstructured":"Macrae, C. F. et al. Mercury CSD 2.0\u2014new features for the visualization and investigation of crystal structures. J. Appl. Crystallogr. 41(2), 466\u2013470 (2008).","journal-title":"J. Appl. Crystallogr."},{"key":"44557_CR45","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"44557_CR46","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.drudis.2006.06.013","volume":"11","author":"IV Tetko","year":"2006","unstructured":"Tetko, I. V., Bruneau, P., Mewes, H. W., Rohrer, D. C. & Poda, G. I. Can we estimate the accuracy of ADME\u2013Tox predictions?. Drug Discov. Today 11, 700\u2013707 (2006).","journal-title":"Drug Discov. Today"},{"key":"44557_CR47","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.2147\/IJN.S120847","volume":"12","author":"Y-S Jian","year":"2017","unstructured":"Jian, Y.-S. et al. Hyaluronic acid\u2013nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo. Int. J. Nanomed. 12, 2315\u20132333 (2017).","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"44557_CR48","first-page":"609","volume":"5","author":"PV Swamy","year":"2015","unstructured":"Swamy, P. V. et al. Dissolution rate enhancement of Nimesulide using electro-spinning and cogrinding techniques: A comparative study. Am. J. Pharm. Tech. Res. 5(4), 609\u2013624 (2015).","journal-title":"Am. J. Pharm. Tech. Res."},{"key":"44557_CR49","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.3390\/ma14247715","volume":"14","author":"M Georgescu","year":"2021","unstructured":"Georgescu, M., Meltzer, V., St\u0103nculescu, I. & Pincu, E. Thermal behavior of the nimesulide-salicylic acid eutectic mixtures prepared by mechanosynthesis and recrystallization. Materials 14, 7715 (2021).","journal-title":"Materials"},{"issue":"3","key":"44557_CR50","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s10973-013-3294-x","volume":"115","author":"DA G\u00e1lico","year":"2013","unstructured":"G\u00e1lico, D. A. et al. Thermoanalytical study of nimesulide and their recrystallization products obtained from solutions of several alcohols. J. Therm. Anal. Calorim. 115(3), 2385\u20132390 (2013).","journal-title":"J. Therm. Anal. Calorim."},{"key":"44557_CR51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.drudis.2010.11.002","volume":"16","author":"TJ Ritchie","year":"2011","unstructured":"Ritchie, T. J., Ertl, P. & Lewis, R. The graphical representation of ADME-related molecule properties for medicinal chemists. Drug Discov. Today 16, 65\u201372 (2011).","journal-title":"Drug Discov. Today"},{"issue":"6","key":"44557_CR52","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1021\/ci700257y","volume":"47","author":"T Cheng","year":"2007","unstructured":"Cheng, T. et al. Computation of octanol\u2212water partition coefficients by guiding an additive model with knowledge. J. Chem. Inf. Model. 47(6), 2140\u20132148 (2007).","journal-title":"J. Chem. Inf. Model."},{"key":"44557_CR53","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1021\/jm000942e","volume":"43","author":"P Ertl","year":"2000","unstructured":"Ertl, P., Rohde, B. & Selzer, P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem. 43, 3714\u20133717 (2000).","journal-title":"J. Med. Chem."},{"issue":"3","key":"44557_CR54","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1021\/ci034243x","volume":"44","author":"JS Delaney","year":"2004","unstructured":"Delaney, J. S. ESOL: Estimating aqueous solubility directly from molecular structure. J. Chem. Inf. Comput. 44(3), 1000\u20131005 (2004).","journal-title":"J. Chem. Inf. Comput."},{"key":"44557_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug. Deliv. Rev. 46, 3\u201326 (2001).","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"44557_CR56","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1021\/jm0492002","volume":"48","author":"YC Martin","year":"2005","unstructured":"Martin, Y. C. A bioavailability score. J. Med. Chem. 48, 3164\u20133170 (2005).","journal-title":"J. Med. Chem."},{"key":"44557_CR57","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","volume":"53","author":"JB Baell","year":"2010","unstructured":"Baell, J. B. & Holloway, G. A. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J. Med. Chem. 53, 2719\u20132740 (2010).","journal-title":"J. Med. Chem."},{"key":"44557_CR58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1758-2946-1-8","volume":"1","author":"P Ertl","year":"2009","unstructured":"Ertl, P. & Schuffenhauer, A. Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J. Cheminform. 1, 8 (2009).","journal-title":"J. Cheminform."},{"key":"44557_CR59","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"A Daina","year":"2016","unstructured":"Daina, A. & Zoete, V. A BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules. Chem. Med. Chem. 11, 1117\u20131121 (2016).","journal-title":"Chem. Med. Chem."},{"key":"44557_CR60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.addr.2015.03.001","volume":"86","author":"F Montanari","year":"2015","unstructured":"Montanari, F. & Ecker, G. F. Prediction of drug-ABC-transporter interaction\u2013Recent advances and future challenges. Adv. Drug Deliv. Rev. 86, 17\u201326 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"44557_CR61","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/j.1471-4159.2006.04280.x","volume":"100","author":"E Candelario-Jalil","year":"2007","unstructured":"Candelario-Jalil, E. et al. Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats. J. Neurochem. 100(4), 1108\u20131120 (2007).","journal-title":"J. Neurochem."},{"issue":"4","key":"44557_CR62","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.phrs.2008.03.003","volume":"57","author":"E Candelariojalil","year":"2008","unstructured":"Candelariojalil, E. Nimesulide as a promising neuroprotectant in brain ischemia: New experimental evidence. Pharmacol. Res. 57(4), 266\u2013273 (2008).","journal-title":"Pharmacol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44557-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44557-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44557-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T21:31:53Z","timestamp":1700429513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44557-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["44557"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-44557-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]},"assertion":[{"value":"30 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Title compounds are protected by European patent application no. EP22208962 submitted by the authors of this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17268"}}